Correlation Between Fairfax Fin and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fairfax Fin and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fairfax Fin and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fairfax Fin Hld and Pfizer Inc CDR, you can compare the effects of market volatilities on Fairfax Fin and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fairfax Fin with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fairfax Fin and Pfizer.

Diversification Opportunities for Fairfax Fin and Pfizer

-0.89
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Fairfax and Pfizer is -0.89. Overlapping area represents the amount of risk that can be diversified away by holding Fairfax Fin Hld and Pfizer Inc CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc CDR and Fairfax Fin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fairfax Fin Hld are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc CDR has no effect on the direction of Fairfax Fin i.e., Fairfax Fin and Pfizer go up and down completely randomly.

Pair Corralation between Fairfax Fin and Pfizer

Assuming the 90 days trading horizon Fairfax Fin Hld is expected to generate 0.59 times more return on investment than Pfizer. However, Fairfax Fin Hld is 1.7 times less risky than Pfizer. It trades about 0.26 of its potential returns per unit of risk. Pfizer Inc CDR is currently generating about -0.07 per unit of risk. If you would invest  2,158  in Fairfax Fin Hld on September 27, 2024 and sell it today you would earn a total of  342.00  from holding Fairfax Fin Hld or generate 15.85% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Fairfax Fin Hld  vs.  Pfizer Inc CDR

 Performance 
       Timeline  
Fairfax Fin Hld 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Fairfax Fin Hld are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating technical indicators, Fairfax Fin sustained solid returns over the last few months and may actually be approaching a breakup point.
Pfizer Inc CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Fairfax Fin and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fairfax Fin and Pfizer

The main advantage of trading using opposite Fairfax Fin and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fairfax Fin position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind Fairfax Fin Hld and Pfizer Inc CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope